← All trials
NCT00001309
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 23, 1997
- Primary completion
- Aug 25, 1999
- Completion date
- Mar 4, 2019
- First posted
- Nov 4, 1999
- Last posted
- Dec 19, 2022
- Enrollment
- 23
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.